A new era in the pharmacologic management of type 2 diabetes.
This article offers an overview of the variety of pharmacologic treatments available to Type 2 diabetes patients. This surge of options has unfolded over the past 7-8 years, and has made the "one treatment fits all" approach an antiquated concept. A basic understanding of the complex physiology underlying Type 2 diabetes is addressed and is a prerequisite to understanding the mechanisms of the various medications. By grouping the oral agents for diabetes into physiologic categories, it is hoped that the reader will attain a clear image of these medications, both singularly and in combination.
Fleishman
S L
SL
Alta Bates Summit Medical Center, Berkeley, California, USA.
D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D005947:Glucose / Q000096:biosynthesis; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000096:biosynthesis; D007333:Insulin Resistance; D008099:Liver / Q000378:metabolism
D007004:Hypoglycemic Agents; D007328:Insulin; D005947:Glucose